Ephrata Cancer Center Ephrata, PA - 17522

Ephrata Cancer Center is categorized under Oncologists in Ephrata, PA and active since 1998.

Ephrata Cancer Center was established in 1998, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Joanne Martin, Office Manager at the company’s single location by writing to 460 North Reading Road, Ephrata, Pennsylvania PA 17522 or by phoning (717) 738-4070. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ephrata Cancer Center
Contact Person: Joanne Martin, Office Manager
Address: 460 North Reading Road, Ephrata, Pennsylvania 17522
Phone Number: (717) 738-4070
Website Address: ephratahospital.org
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1998
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Ephrata Cancer Center was started in 1998 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Joanne Martin, Office Manager for inquiries that concern Ephrata Cancer Center by calling the company number (717) 738-4070, as your correspondence is most welcome. Additionally, the physical location of the single location of Ephrata Cancer Center can be found at the coordinates 40.19597,-76.1705 as well as the street address 460 North Reading Road in Ephrata, Pennsylvania 17522.

For its online presence, you may visit Ephrata Cancer Center’s website at ephratahospital.org and engage with its social media outlets through on Twitter and on Facebook.